This Web site is intended for use by medical professionals only. The information on this Web site is intended for informational purposes only and does not constitute any medical advice.
Cervilenz Inc. only collects personally identifiable information (e.g., name, email address, phone) that you choose to provide. Any personal information will be used to contact you regarding any forms you choose to complete on this Web site but will not be shared or sold to any third party. By providing your personal or other information on forms submitted through this Web site, you are giving your consent to use of that information by Cervilenz Inc. including use of content such as testimonials on this Web site and in hardcopy publications. If you wish to remain anonymous for that use, please note that limitation of use when submitting content on any forms.
If you do not want to receive e-mail from us in the future, please contact us via email to firstname.lastname@example.org or by call Customer Service at 440-337-4260.
Upon request, we provide site visitors with access to a description of information that we maintain about them. Consumers can access this information by writing to email@example.com. Consumers can have this information corrected by writing to firstname.lastname@example.org.
CerviLenz® is a trademark of Cervilenz Inc. All content on this Web site is copyright of Cervilenz Inc. 2010.
Cervilenz Inc. reserves the right to change this notice under which the Cervilenz Inc. Web site is offered. You are responsible for regularly reviewing these terms and conditions. If you feel that this site is not following its stated information policy, you may contact us at email@example.com, inform state or local chapters of the Better Business Bureau, or contact The Federal Trade Commission by phone at 202.FTC-HELP (202.382.4357) or electronically at www.ftc.gov/ftc/complaint.htm
In an independent survey of obstetricians, 90% said that the new society practice guidelines represent a change in practice. Seventy-two percent said they are likely to add cervical length screening to routine prenatal care. The primary concerns about implementing universal TVU screening are cost and time barriers.
Among obstetricians surveyed, 95% see a role for the CerviLenz device in supporting adoption of universal screening, 80% specifically in their practice. Here are some of the things they said:
“A great way to screen for TVU.” “Probably much cheaper than ultrasound.” “This is all you’d need for 95% of your patients.” “Really quick and easy.” “My nurse could use this. “ “Patients would appreciate not having to wait or schedule an ultrasound elsewhere.”